Patterns of coronary artery disease trends in patients with nephrotic syndrome: A national inpatient study

被引:0
作者
Regis, Stacey C. [1 ,3 ]
Del Castillo-Rix, Daniel [1 ]
Colombo, Rosario [2 ]
机构
[1] Univ Miami, Jackson Mem Hosp, Miami, FL USA
[2] Jackson Mem Hosp, Miami, FL USA
[3] 1611 NW 12th Ave, Miami, FL 33136 USA
关键词
Coronary artery disease; Hyperlipidemia; Nephrotic syndrome; SYNDROME MECHANISMS; DYSLIPIDEMIA;
D O I
10.1016/j.ijcard.2024.132200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Individuals with nephrotic syndrome (NS) are thought to have elevated cardiovascular risk because of a known association with hyperlipidemia. Unfortunately, no studies have compared the cardiovascular risk profiles of individual nephrotic syndromes. This study explores the prevalence and patterns of coronary artery disease (CAD) in patients with different types of NS, which may aid in developing risk reduction strategies. Methods: This retrospective study queried data from the National Inpatient Sample database spanning 2016-2020 and included patients over the age of 18 years with minimal change disease (MCD), membranous nephropathy (MN), and focal segmental glomerulosclerosis (FSGS). We analyzed the prevalence and trends of hyperlipidemia and CAD in the study population. Results: Of the 15,025 cohort, there were 3625 (24.1%) MCD, 4160 (27.7%) MN, and 7315 (48.7%) FSGS. Patients with MN were found to be older with a higher prevalence of hyperlipidemia and CAD compared to other groups. The odds of developing CAD when adjusting for confounding factors were increased in FSGS (adjusted odds [aOR] 1.570, 95% CI 1.406-1.753, p < 0.001) while reduced in MCD (aOR 0.671, 95% CI 0.580-0.777, p < 0.001) and MN (aOR 0.782, 95% CI 0.698-0.876, p < 0.001). Conclusions: The divergent results of the different NS types highlight the need for targeted research to better understand and characterize the distinct cardiovascular risk profiles inherent in each type of nephrotic disease for risk stratification.
引用
收藏
页数:5
相关论文
共 28 条
[1]   Coronary Artery Disease [J].
Agrawal, Harsh ;
Choy, Ho-hin K. ;
Liu, Jason ;
Auyoung, Matthew ;
Albert, Michelle A. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (07) :E185-E192
[2]   Dyslipidaemia in nephrotic syndrome: mechanisms and treatment [J].
Agrawal, Shipra ;
Zaritsky, Joshua J. ;
Fornoni, Alessia ;
Smoyer, William E. .
NATURE REVIEWS NEPHROLOGY, 2018, 14 (01) :57-+
[3]  
[Anonymous], 2023, Overview of the National (Nationwide) Inpatient Sample (NIS)
[4]  
Ashley E.A., 2004, CARDIOLOGY EXPLAINED
[5]   Nephrotic Syndrome and Statin Therapy: An Outcome Analysis [J].
Busuioc, Ruxandra ;
Stefan, Gabriel ;
Stancu, Simona ;
Zugravu, Adrian ;
Mircescu, Gabriel .
MEDICINA-LITHUANIA, 2023, 59 (03)
[6]  
Cases A, 2005, KIDNEY INT, V68, P87
[7]  
Catapano Alberico L, 2017, Rev Esp Cardiol (Engl Ed), V70, P115, DOI 10.1016/j.rec.2017.01.002
[8]  
Elixhauser A., 1996, Clinical classifications for health policy research, version 2: hospital inpatient statistics
[9]   Distinct urinary lipid profile in children with focal segmental glomerulosclerosis [J].
Erkan, Elif ;
Zhao, Xueheng ;
Setchell, Kenneth ;
Devarajan, Prasad .
PEDIATRIC NEPHROLOGY, 2016, 31 (04) :581-588
[10]   CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASE IN CHRONIC KIDNEY DISEASE [J].
Foley, Robert N. .
JOURNAL OF RENAL CARE, 2010, 36 :4-8